11-7796887-C-T
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_153444.1(OR5P2):c.56G>A(p.Gly19Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000848 in 1,594,818 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_153444.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR5P2 | NM_153444.1 | c.56G>A | p.Gly19Asp | missense_variant | Exon 1 of 1 | ENST00000329434.3 | NP_703145.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR5P2 | ENST00000329434.3 | c.56G>A | p.Gly19Asp | missense_variant | Exon 1 of 1 | 6 | NM_153444.1 | ENSP00000331823.2 | ||
ENSG00000271758 | ENST00000527565.1 | n.542+82120G>A | intron_variant | Intron 5 of 5 | 3 | |||||
ENSG00000254951 | ENST00000529488.5 | n.532-42366G>A | intron_variant | Intron 5 of 5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000618 AC: 91AN: 147328Hom.: 5 Cov.: 31
GnomAD3 exomes AF: 0.000592 AC: 145AN: 244768Hom.: 2 AF XY: 0.000552 AC XY: 73AN XY: 132262
GnomAD4 exome AF: 0.000872 AC: 1262AN: 1447382Hom.: 33 Cov.: 32 AF XY: 0.000844 AC XY: 608AN XY: 720218
GnomAD4 genome AF: 0.000617 AC: 91AN: 147436Hom.: 5 Cov.: 31 AF XY: 0.000500 AC XY: 36AN XY: 71982
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.56G>A (p.G19D) alteration is located in exon 1 (coding exon 1) of the OR5P2 gene. This alteration results from a G to A substitution at nucleotide position 56, causing the glycine (G) at amino acid position 19 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at